(VIANEWS) – Harmony Biosciences Holdings (HRMY), DexCom (DXCM), Inter Parfums (IPAR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Harmony Biosciences Holdings (HRMY)
29.9% sales growth and 61.58% return on equity
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy in the United States. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Earnings Per Share
As for profitability, Harmony Biosciences Holdings has a trailing twelve months EPS of $2.9.
PE Ratio
Harmony Biosciences Holdings has a trailing twelve months price to earnings ratio of 10.97. Meaning, the purchaser of the share is investing $10.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 61.58%.
Moving Average
Harmony Biosciences Holdings’s worth is way under its 50-day moving average of $38.82 and way under its 200-day moving average of $48.14.
Sales Growth
Harmony Biosciences Holdings’s sales growth is 37.4% for the ongoing quarter and 29.9% for the next.
2. DexCom (DXCM)
23.6% sales growth and 13.23% return on equity
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices for specific and permitted use cases, including non-medical device applications, medical device data analysis, integrated continuous glucose monitoring systems (iCGM) secondary display alarms, active patient monitoring, and treatment decisions; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, DexCom has a trailing twelve months EPS of $0.71.
PE Ratio
DexCom has a trailing twelve months price to earnings ratio of 169.66. Meaning, the purchaser of the share is investing $169.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.23%.
Volume
Today’s last reported volume for DexCom is 325016 which is 85.68% below its average volume of 2270390.
Yearly Top and Bottom Value
DexCom’s stock is valued at $120.46 at 11:22 EST, under its 52-week high of $126.44 and way higher than its 52-week low of $66.89.
Moving Average
DexCom’s worth is higher than its 50-day moving average of $116.29 and way above its 200-day moving average of $105.50.
Sales Growth
DexCom’s sales growth is 20.8% for the current quarter and 23.6% for the next.
3. Inter Parfums (IPAR)
15.2% sales growth and 19.79% return on equity
Inter Parfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products in the United States and internationally. The company operates in two segments, European Based Operations and United States Based Operations. It offers its fragrance and cosmetic products under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade New York, Lanvin, Montblanc, Paul Smith, Repetto, Rochas, S.T. Dupont, Van Cleef & Arpels, Abercrombie & Fitch, Anna Sui, bebe, Dunhill, Hollister, French Connection, Graff, GUESS, Lily Aldridge, MCM, Bella Vita, and Oscar de la Renta brand names, as well as under the Intimate and Aziza names. It sells its products to department stores, specialty stores, duty free shops, beauty retailers, and domestic and international wholesalers, and distributors, as well as through e-commerce. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Inter Parfums, Inc. was founded in 1982 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Inter Parfums has a trailing twelve months EPS of $3.79.
PE Ratio
Inter Parfums has a trailing twelve months price to earnings ratio of 40.3. Meaning, the purchaser of the share is investing $40.3 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.79%.
Volume
Today’s last reported volume for Inter Parfums is 104964 which is 26.4% below its average volume of 142631.
Moving Average
Inter Parfums’s worth is above its 50-day moving average of $143.18 and way above its 200-day moving average of $104.45.
Previous days news about Inter Parfums(IPAR)
- According to Zacks on Monday, 8 May, "Some better-ranked stocks are Inter Parfums (IPAR Quick QuoteIPAR – Free Report) , General Mills (GIS Quick QuoteGIS – Free Report) and Kimberly-Clark Corporation (KMB Quick QuoteKMB – Free Report) .IPAR has an expected long-term earnings growth rate of 15% and a trailing four-quarter earnings surprise of 36.2%, on average. "
- Inter parfums (ipar) Q1 earnings beat estimates. According to Zacks on Monday, 8 May, "While Inter Parfums has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
- According to Zacks on Tuesday, 9 May, "Some better-ranked stocks are Inter Parfums (IPAR Quick QuoteIPAR – Free Report) , General Mills (GIS Quick QuoteGIS – Free Report) and Kimberly-Clark Corporation (KMB Quick QuoteKMB – Free Report) .IPAR has an expected long-term earnings growth rate of 15% and a trailing four-quarter earnings surprise of 36.2%, on average. "
4. Fulton Financial Corporation (FULT)
14.3% sales growth and 11.22% return on equity
Fulton Financial Corporation operates as a financial holding company that provides consumer and commercial banking products and services. It accepts various checking accounts and savings deposit products, certificates of deposit, and individual retirement accounts. The company also offers secured consumer loans, including home equity loans and lines of credit, automobile loans, personal lines of credit, and checking account overdraft protection; construction and jumbo residential mortgage loans; and commercial lending products comprising commercial real estate, commercial and industrial, and construction loans, as well as equipment lease financing loans. In addition, it provides letters of credit, cash management services, and traditional deposit products; and wealth management services, including investment management, trust, brokerage, insurance, and investment advisory services. Further, the company owns passive investments, as well as trust preferred securities; and sells various life insurance products. It provides its products and services through traditional financial center banking, as well as through a network of automated teller machines, telephone banking, mobile banking, and online banking. The company operated branches in Pennsylvania, Maryland, Delaware, New Jersey, and Virginia. Fulton Financial Corporation was incorporated in 1882 and is headquartered in Lancaster, Pennsylvania.
Earnings Per Share
As for profitability, Fulton Financial Corporation has a trailing twelve months EPS of $1.68.
PE Ratio
Fulton Financial Corporation has a trailing twelve months price to earnings ratio of 6.16. Meaning, the purchaser of the share is investing $6.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.22%.
Volume
Today’s last reported volume for Fulton Financial Corporation is 561183 which is 57.92% below its average volume of 1333780.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 30, 2023, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 5.73%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9%, now sitting on 999.42M for the twelve trailing months.
5. Autodesk (ADSK)
7.9% sales growth and 82.55% return on equity
Autodesk, Inc. provides 3D design, engineering, and entertainment technology solutions worldwide. The company offers AutoCAD Civil 3D, a surveying, design, analysis, and documentation solution for civil engineering, including land development, transportation, and environmental projects; BuildingConnected, a SaaS preconstruction solution; AutoCAD, a software for professional design, drafting, detailing, and visualization; AutoCAD LT, a drafting and detailing software; computer-aided manufacturing (CAM) software for computer numeric control machining, inspection, and modelling for manufacturing; Fusion 360, a 3D CAD, CAM, and computer-aided engineering tool; and Industry Collections tools for professionals in architecture, engineering and construction, product design and manufacturing, and media and entertainment collection industries. It also provides Inventor tools for 3D mechanical design, simulation, analysis, tooling, visualization, and documentation; Vault, a data management software to manage data in one central location, accelerate design processes, and streamline internal/external collaboration; Maya and 3ds Max software products that offer 3D modeling, animation, effects, rendering, and compositing solutions; and ShotGrid, a cloud-based software for review and production tracking in the media and entertainment industry. It sells its products and services to customers directly, as well as through a network of resellers and distributors. Autodesk, Inc. was incorporated in 1982 and is headquartered in San Francisco, California.
Earnings Per Share
As for profitability, Autodesk has a trailing twelve months EPS of $3.72.
PE Ratio
Autodesk has a trailing twelve months price to earnings ratio of 51.88. Meaning, the purchaser of the share is investing $51.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 82.55%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 8.4% and 7.3%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Autodesk’s EBITDA is 151.24.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.8%, now sitting on 5.01B for the twelve trailing months.
Yearly Top and Bottom Value
Autodesk’s stock is valued at $193.01 at 11:22 EST, way below its 52-week high of $235.01 and way above its 52-week low of $163.20.
6. Balchem Corporation (BCPC)
6.4% sales growth and 10.73% return on equity
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
Earnings Per Share
As for profitability, Balchem Corporation has a trailing twelve months EPS of $3.06.
PE Ratio
Balchem Corporation has a trailing twelve months price to earnings ratio of 41.98. Meaning, the purchaser of the share is investing $41.98 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.73%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Balchem Corporation’s EBITDA is 4.9.
Sales Growth
Balchem Corporation’s sales growth is 3.7% for the present quarter and 6.4% for the next.
Yearly Top and Bottom Value
Balchem Corporation’s stock is valued at $128.46 at 11:22 EST, way below its 52-week high of $143.88 and way above its 52-week low of $110.15.
